June 14, 2024
Electroporation Instruments Market

Electroporation Instruments Market is Enabling Novel Drug Delivery by Microelectroporation

The electroporation instruments market comprises products used to introduce molecules such as drugs, DNA, RNA, and proteins into cells and tissues. Electroporation instruments use electrical pulses to reversibly or permanently create nanoscale pores in the cell membrane, allowing transport of molecules across the cell membrane that otherwise would be unable to enter the cell. These instruments find widespread applications in gene delivery, DNA vaccination, drug and RNA delivery, and cell fusion. The Global Electroporation Instruments Market Size is estimated to be valued at US$ 279.26 Bn in 2024 and is expected to exhibit a CAGR of 12% over the forecast period 2024 to 2030.

Key Takeaways

Key players operating in the electroporation instruments market are Arduino, Adafruit, SparkFun, Seeed Studio, Microchip, NXP Semiconductors, STMicroelectronics, Texas Instruments, Cypress Semiconductor, Silicon Labs, Renesas Electronics, Infineon Technologies, Maxim Integrated, ON Semiconductor, Microchip Technology, Semtech, Analog Devices, ROHM Semiconductor, FTDI Chip, Intel. Electroporation is gaining traction for its ability to deliver nucleic acids and chemotherapeutics into cells in a localized and targeted manner. This is expected to drive the growing demand for electroporation instruments in gene and drug delivery applications. Major players in the market are expanding their presence globally with a focus on emerging economies in Asia Pacific and Latin America to tap the potential offered by these markets.

Market key trends

Microelectroporation is emerging as a key trend in the electroporation instruments market. It enables targeted and localized delivery of molecules into tissues with micron-level precision. This novel approach helps overcome challenges with conventional electroporation like damage to surrounding tissues. Leading players are developing customized microelectroporation systems and tools to enable applications like intradermal and transdermal drug delivery with minimally invasive procedures. This is expected to further support the growth of electroporation instruments market over the forecast period

Porter’s Analysis

Threat of new entrants: Medium threat as large initial investments are required to set up manufacturing facilities and to acquire patents and distribution networks. However there are low costs of production itself.
Bargaining power of buyers: Moderate bargaining power as there exist a number of established suppliers in this highly competitive market.
Bargaining power of suppliers: Low to medium bargaining power as there are some dominant suppliers but substitutes exist.
Threat of new substitutes: High threat as new bioengineering and biotechnological methods are emerging, substituting electroporation.
Competitive rivalry: High competitive rivalry exists amongst established players leading to continuous innovation, low prices and improved quality.

The North American region accounts for the largest share of the electroporation instruments market in terms of value, owing to the high adoption of new technologies, presence of majority of global players in the region and accessibility of resources.

The Asia Pacific region is poised to grow at the fastest rate for the electroporation instruments market during the forecast period. This is attributed to factors such rising healthcare expenditure, increasing awareness about therapies, presence of contract research organizations and growth of genomics and proteomics research in emerging countries such as China and India

1.Source: Coherent Market Insights, Public sources, Desk research
2.We have leveraged AI tools to mine information and compile it